Navigation Links
The Best Radiation Therapy Solution just got Better
Date:7/18/2012

SUNNYVALE, Calif., July 18, 2012 /PRNewswire/ -- IntraOp Medical Corporation (OTC: IOPD.PK - News) installed the 10th of the next generation Mobetrons last week at Helios-Kliniken (helios-kliniken.de) in Berlin Germany.  The Mobetron is used for electron IORT (IOERT), which has demonstrated the best overall clinical results of any breast cancer treatment, resulting in 10 year recurrence rates as low as 1%.  Currently each Mobetron in Germany treats between 250-350 breast cancer patients per year with IOERT. Many of these patients are also eligible for oncoplastic reconstruction which eliminates the need for additional cosmetic surgery and speeds the process of "emotional reconstruction".  Germany is a leader of evidence based medicine.  The rapid adoption of IOERT for breast cancer treatment is immediately allowing thousands of women with breast cancer to achieve better results and cosmesis, over a shorter treatment course.  IOERT provides the treatment flexibility to accommodate nearly all breast patients including younger pre-menopausal patients.

"IOERT is becoming the gold standard in the successful treatment of cancer," says Ernesto G. Lanzotti, Director of MD51 Germany GmbH, IntraOp Medical European distributor.  "We are very proud to start cooperating with Helios Kliniken because we understand the importance from both a treatment and medical science aspect and Helios-Kliniken is a leader in this regard."

The next generation Mobetron has also added a new benefit to the environment as well.  The Mobetron provides radiation therapy (RT) more efficiently than any other RT technique, using less time, less energy, and producing little to no waste.  The Mobetron can deliver a complete course of radiation therapy for select breast cancer candidates in 2 minutes using less than one tenth of a kilowatt hour (kWh) of electricity.  The same treatment using conventional external beam radiation therapy requires 90 minutes of treatment (beam) over 30 days and uses over 100 kWh's for treatment and cooling.

The Mobetron is a true linear accelerator and generates only the radiation it needs for a given treatment without having to use active radioactive radiation sources.  The Mobetron does not use disposable applicators like some of the other methods to treat cancers Intra-Operatively.  This is effective for reducing both cost and waste.  The Healthcare industry is the second largest producer of waste behind the food service industry and this will continue to be an area of great attention.  "Eventually, policy will be enacted to discourage waste as seen in other industries, and we want to help lead this initiative," said John Powers, IntraOp Medical's CEO.  For these reasons it is no surprise that the Mobetron is gaining more attention worldwide with Mobetrons recently shipping to new markets in Saudi Arabia and Turkey.

About IntraOp

IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer IOERT safely and effectively for all cancer patients. The Mobetron is the first IOERT device designed for use in existing operating rooms and has been used to treat over 20 different cancer indications. Mobetron benefits include: increased survival rates, better local tumor control, shorter treatment cycles, and happier patients with fewer side effects. Leading hospitals and clinics throughout the world use the Mobetron as a vital part of their comprehensive cancer program. For more information email info@intraopmedical.com or call 408-636-1020 x128.

About Helios

The HELIOS Hospital Group ranks among the largest and most medically advanced hospital groups in Germany. Since 2005 HELIOS is part of the global healthcare provider Fresenius Fresenius SE & Co.KGaA.

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. By making these forward-looking statements, the Company can give no assurances that transactions described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.


'/>"/>
SOURCE IntraOp Medical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Radiation Therapy in Oncology Drug Pipeline Update 2012
2. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
3. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
4. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
5. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
6. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
7. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
8. Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
9. United States Market for Psoriatic Arthritis Pharmacotherapy
10. Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
11. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... -- Radiology has become the number one diagnostic tool ... to the number one ranking as a result.  More ... as the most complete and reliable method for clinical ... pain an MRI may confirm a suspected herniated disc ... entirely different treatment protocols.  In these circumstances, patients need ...
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced it has earned a spot ... 2017" list. The Company was ranked among 500 U.S. ... Employers and Healthcare Equipment and Services. The ... on an anonymous, independent survey of over 30,000 employees ...
(Date:5/9/2017)...  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... focused on the development of oral drug delivery ... Office has granted Oramed a patent titled, "Methods ... patent covers Oramed,s invention of an oral glucagon-like ... incretin hormone that stimulates the secretion of insulin ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to announce the ... USA Today, which will educate readers on how to take care of all aspects ... focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, shares her ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... a new educational seminar to focus on current legislative activity and the latest ... begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
(Date:5/26/2017)... ... 26, 2017 , ... On May 24, the Congressional Budget Office (CBO) projected ... on May 4, would result in 23 million Americans losing their health insurance by ... Patient Protection and Affordable Care Act (ACA). , “It is clear from the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Silver Birch of Hammond, a new ... on more than four acres of land at 5620 Sohl Avenue in Hammond, serves ... square-foot building includes 125 studio and one-bedroom apartments. Each of the private apartments at ...
Breaking Medicine News(10 mins):